Koers Shanghai Labway Clinical Laboratory Co., Ltd
Aandelen
301060
CNE100004RG8
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,77 CNY | -0,20% | +8,19% | -26,49% |
Omzet 2022 | 4,2 mld. 580 mln. 542 mln. | Omzet 2023 | 1,67 mld. 231 mln. 216 mln. | Marktkapitalisatie | 5,32 mld. 735 mln. 687 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 617 mln. 85,15 mln. 79,64 mln. | Nettowinst (verlies) 2023 | -142 mln. -19,6 mln. -18,33 mln. | EV/omzet 2022 | 1,77 x |
Nettoliquiditeiten 2022 | 421 mln. 58,13 mln. 54,37 mln. | Nettoliquiditeiten 2023 * | - 0 0 | EV/omzet 2023 | 3,18 x |
K/w-verhouding 2022 |
12,7
x | K/w-verhouding 2023 |
-37,6
x | Werknemers | 1.878 |
Dividendrendement 2022 |
1,53% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 32,29% |
1 dag | -0,20% | ||
1 week | +8,19% | ||
Lopende maand | -18,24% | ||
1 maand | -17,76% | ||
3 maanden | -13,54% | ||
6 maanden | -24,03% | ||
Lopend jaar | -26,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 20-08-15 |
Xi Gu Wang
DFI | Director of Finance/CFO | 54 | 22-07-22 |
Zhi Sen Mao
BRD | Director/Board Member | 64 | 17-12-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lei Wang
BRD | Director/Board Member | 42 | 17-12-21 |
Zhi Hua He
BRD | Director/Board Member | 61 | 20-08-15 |
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 20-08-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.07% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 9,77 | -0,20% | 5 898 500 |
25-04-24 | 9,79 | +1,14% | 5 012 100 |
24-04-24 | 9,68 | +2,65% | 6 221 600 |
23-04-24 | 9,43 | +3,63% | 6 003 200 |
22-04-24 | 9,1 | +0,78% | 4 534 926 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-26,49% | 540 mln. | |
-17,89% | 8,25 mld. | |
+39,20% | 3,57 mld. | |
-39,11% | 2,46 mld. | |
-8,06% | 2,46 mld. | |
-7,35% | 2,38 mld. | |
-12,61% | 1,81 mld. | |
-19,01% | 1,55 mld. | |
-40,66% | 1,21 mld. | |
+7,56% | 1,11 mld. |